Sandoz's Carol Lynch Highlights Decade Of Biosimilar Dominance And Plans For Many More Winning Years

 
• By Lucie Ellis-Taitt
  
Carol Lynch
Carol Lynch, Global Head of Biopharmaceuticals & Oncology at Sandoz
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip